美國
US 12,702,695 B2
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
US 12,702,695 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：Nammi Therapeutics, Inc.。PDF 可在本頁下載，未登入每天最多 5 篇。
- 申請人
- Nammi Therapeutics, Inc.
- 發明人
- David Stover; Dhruba Bharali; Bruce A. Hay; Tahmineh Safaie
- 公開日
- 2026-08-11
- 申請日
- 2023-03-10
- 文件種類
- B2 核准公告
- 也寫作
- US 12,702,695 B2 · US12702695 · 12702695
摘要
Formulated and/or co-formulated liposomes comprising TLR prodrugs and/or TLR Lipid Moieties and methods of making the liposomes are disclosed herein. The TLR prodrug compositions comprise a drug moiety, a lipid moiety, and linkage unit that inhibit Toll-Like Receptor (e.g., TLR1/2, TLR4, and/or TLR7). The TLR prodrugs can be formulated and/or co-formulated into a liposome to provide a method of treating cancer, immunological disorders, and other disease by utilizing a targeted drug delivery vehicle.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）